NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,099 | +2.3% | 108,961 | +1.3% | 0.53% | +2.7% |
| Q2 2023 | $10,852 | +11.3% | 107,538 | +1.4% | 0.52% | +3.8% |
| Q1 2023 | $9,754 | +1.8% | 106,026 | +0.4% | 0.50% | -3.8% |
| Q4 2022 | $9,581 | -99.9% | 105,606 | -1.7% | 0.52% | +14.3% |
| Q3 2022 | $8,170,000 | -10.9% | 107,486 | -0.9% | 0.46% | -4.8% |
| Q2 2022 | $9,165,000 | -0.6% | 108,418 | +3.2% | 0.48% | +16.3% |
| Q1 2022 | $9,222,000 | +7.4% | 105,098 | +7.1% | 0.41% | +6.5% |
| Q4 2021 | $8,584,000 | +6.3% | 98,137 | -0.6% | 0.39% | +4.6% |
| Q3 2021 | $8,075,000 | -11.0% | 98,738 | -0.8% | 0.37% | -8.2% |
| Q2 2021 | $9,077,000 | +7.2% | 99,490 | +0.4% | 0.40% | +2.0% |
| Q1 2021 | $8,467,000 | +9.5% | 99,057 | +21.0% | 0.40% | +3.4% |
| Q4 2020 | $7,732,000 | +6.0% | 81,880 | -2.4% | 0.38% | -23.6% |
| Q3 2020 | $7,292,000 | +1.1% | 83,860 | +1.6% | 0.50% | +20.8% |
| Q2 2020 | $7,212,000 | +10.6% | 82,575 | +4.4% | 0.41% | -5.9% |
| Q1 2020 | $6,522,000 | -9.9% | 79,100 | +3.5% | 0.44% | +12.2% |
| Q4 2019 | $7,235,000 | +24.7% | 76,412 | +14.4% | 0.39% | +38.5% |
| Q3 2019 | $5,802,000 | -6.4% | 66,772 | -1.7% | 0.28% | -5.0% |
| Q2 2019 | $6,202,000 | -5.3% | 67,927 | -0.3% | 0.30% | -4.5% |
| Q1 2019 | $6,552,000 | +4.8% | 68,155 | -6.4% | 0.31% | -5.5% |
| Q4 2018 | $6,252,000 | +0.2% | 72,853 | +0.6% | 0.33% | +25.5% |
| Q3 2018 | $6,237,000 | +11.2% | 72,389 | -2.5% | 0.26% | +1.2% |
| Q2 2018 | $5,610,000 | -9.3% | 74,269 | -2.9% | 0.26% | -13.9% |
| Q1 2018 | $6,185,000 | -7.9% | 76,494 | -4.4% | 0.30% | -2.3% |
| Q4 2017 | $6,718,000 | -2.5% | 80,010 | -0.3% | 0.31% | -13.9% |
| Q3 2017 | $6,892,000 | +27.4% | 80,274 | +23.8% | 0.36% | +22.1% |
| Q2 2017 | $5,411,000 | +12.2% | 64,831 | -0.1% | 0.29% | +14.4% |
| Q1 2017 | $4,822,000 | +1.5% | 64,921 | -0.5% | 0.26% | -0.8% |
| Q4 2016 | $4,751,000 | +65.4% | 65,220 | +79.3% | 0.26% | +61.9% |
| Q3 2016 | $2,873,000 | -8.3% | 36,381 | -4.2% | 0.16% | -13.5% |
| Q2 2016 | $3,134,000 | – | 37,986 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |